PHARMACY

Astronaut Kelly named IPC keynote speaker

BY Brian Berk

SUN PRAIRIE, Wis. — The IPC Independent Pharmacy Conference selected astronaut Captain Mark Kelly as its keynote speaker during its April 6-8 conference in Scottsdale, Ariz.

The retired U.S. Naval officer, Kelly will discuss how to better manage teams, deal with changing circumstances and use detailed plans to accomplish remarkable things in the face of seemingly insurmountable obstacles.

“We selected Captain Kelly because of his record of achievements, his hard work and his determination,” said Independent Pharmacy Cooperative CEO Don Anderson. “He is representative of the type of creative problem- solving needed to be a successful community pharmacist in our challenging business environment. We are fortunate and proud to have him join our program.”

Kelly and his brother Capt. Scott Kelly are the only known siblings to have both been in space.

The Independent Pharmacy Cooperative is the nation's largest group purchasing organization owned by independent pharmacy, representing more than 5,000 members.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Adapt Pharma gets FDA approval for 2-mg Narcan Nasal Spray

BY David Salazar
SILVER SPRING, Md. — The Food and Drug Administration has approved a 2-mg formulation of Adapt Pharma’s Narcan Nasal Spray, the company announced Wednesday. 
 
The 2-mg dose is approved for use in patients who are opioid dependent and expected to be at risk for severe opioid withdrawal in situations where there is a low risk for accidental or intentional opioid exposure by household contacts. 
 
The FDA’s approval of the new formulation comes a little more than a year after it approved the nasal spray in a 4-mg formulation. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Lupin intros Ortho-Cyclen 28 generic

BY David Salazar
MUMBAI and BALTIMORE, Md. — Lupin on Tuesday announced the launch of its generic of Ortho-Cyclen 28 (norgestimate and ethinyl estradiol, 0.25 mg/0.035 mg) tablets. The drug is indicated for women of reproductive potential to prevent pregnancy. 
 
The drug had U.S. sales of $204 million for the 12 months ended September 2016, according to QuintilesIMS data. 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?